Who keeps selling PFHO here?

Somebody seems to be bailing in significant volume.

That was me that just bought 5 shares at 62.00. :0

What changed your mind from $100 to $65?

My 63 is now 53. It's about the identical percentage loss.

That's what I mean. I bought at 28 in January and 3 days later it dropped to 23.

Why does it do this every time I buy?

I found I made another purchase today. I had a trade for another 15 shares go through at $62.40.

Given how much the stock is risen, I guess I could have set it a little lower because every once in a while someone wants to sell a few shares.

A Hint That Pacific Health Care Organization's Next Quarter Will Be A Killer

http://seekingalpha.com/article/2218113-a-hint-that-pacific-health-care-organizations-next-quarter-will-be-a-killer

Are you concerned about the age of some of the executives and insiders who hold most of the shares? What if they decide to retire and sell?

Arcam institutional ownership:

msnmoney lists 21.63% institutional and 21.8% mutual fund ownership:

http://investing.money.msn.com/investments/institutional-ownership?symbol=AMAVF

Morningstar shows same percentage:

http://investors.morningstar.com/ownership/shareholders-overview.html?t=AMAVF®ion=usa&culture=en-US&ownerCountry=USA

Fascinating new mobile payment solution works almost everywhere by tricking credit card terminals

http://bgr.com/2014/02/19/loop-mobile-payments-loopwallet-fob/

"These guys" invested in a private placement in Arcam, something most individual retail investors can't do. Their next investment will probably be a private placement, possibly not even in a public company, open only to Swedish accredited investors, and likely the shares are restricted from sale for one or more years.

Jan Barchans helped Arcam get started and become successful by keeping his money in it for eight years, so now you have a chance to invest in a successful company. Most of the posters here don't seem like the type to wait on their investment in a speculative start-up for eight years so perhaps we should be grateful this early investment has made Arcam a viable investment right now.


Given I can't invest in Swedish private placements and sit on the investment for eight years, I am spending no time thinking about what they might do next, and instead keeping an investment in Arcam because it still has big things ahead of it.

.

Why There's a Huge Opportunity in Metal 3-D Printing

"According to 3-D printing service bureau Incodema Group, there's currently a tremendous gap in the metal printing market because General Electric (NYSE: GE ) acquired 3-D metal printing expert Morris Technologies. Incodema Group estimates this acquisition took approximately 50% of the metal 3-D printers related to providing 3-D printing services off the market.

With over 20 years of additive manufacturing experience, Incodema has formed a new company that plans on acquiring more than 100 industrial 3-D printers to fill the void -- half of which will be metal. This creates a unique opportunity for Arcam (NASDAQOTH: AMAVF ) and ExOne (NASDAQ: XONE ) , which both offer 3-D metal printers. Of the two, Arcam seems in the best position to benefit from the current aviation boom because its electron beam melting technology can handle more complicated designs compared to ExOne's binder jetting technology.

http://www.fool.com/investing/general/2014/02/10/why-theres-a-huge-opportunity-in-metal-3-d-printin.aspx

Of interest: China Giant 3D metal printers?

http://www.3ders.org/articles/20140207-china-developing-world-largest-3d-printer--prints-6m-metal-parts-in-one-piece.html

http://www.3dprinterworld.com/article/mammoth-3d-laser-printer-developed-china

Patent litigation is a small part of what the company does and, in fact, has contributed nothing so far. The company has doubled sales of contact-less readers and sells EasyPark and EasyFuel systems worldwide with recurring revenues.

I don't think it is at all. Wait and see. Or read the entire article.

Fast EBM research, a five year project concluding last year to make EBM printing five times faster.

"One of the biggest advantages of EBM over SLS is that it can produce metal parts in significantly less time and at less cost."

"If Arcam AB is able to present their new Fast EBM machine concept whereby 3D printing of high grade metal parts is increased by a factor of five and Arcam AB is able to patent this new technology, shareholders can be more than confident that this small Swedish company will be an absolute winner in metal 3D printing. This is an increase that could drive production of high grade metal parts used in aerospace and medical applications closer to rapid manufacturing from rapid prototyping and small-lot production.

I did a few calls with some project partners and came to the conclusion that we can expect some very good news regarding the "FastEBM" machine on February 7th."

http://seekingalpha.com/article/1968241-3-d-printer-arcam-ab-will-give-an-update-on-their-new-fast-ebm-project-soon?source=cc

Also from the MSN Money article:

>"We believe Arcam's revenue growth will be well above that of the 3D printing industry, driven by penetration of tier-one orthopaedic implant customers and a ramp to volume production by aerospace customers," Canaccord Genuity said.

Arcam sales shot up 73 percent to 133 million Swedish crowns in the first nine months of 2013. It logged a steady stream of printer orders in the fourth quarter, albeit just short of the record level in the final quarter of 2012.>

Volume in the last week is much higher than it has been previously, even taking into account the split. There are also not a lot of shares available. There is not an enormous float.

3-D Printer Arcam AB Will Give An Update On Their New Fast EBM Project Soon

http://seekingalpha.com/article/1968241-3-d-printer-arcam-ab-will-give-an-update-on-their-new-fast-ebm-project-soon

"On December 23, 2013, Oppenheimer Funds increased to 5.2 percent of capital and votes of Arcam, according to a disclosure statement."

The fact is, stocks that go up are the ones it is wisest to hold on to. When absolutely everything is positive for the company, I'm surprised by people acting desperate to sell, and complaining about the hold on shares and time it takes to do a stock split. The stock split is one of the reasons for the success of the stock.

You can ascribe solely psychological reasons to the rise, but that's not the case. A stock split allows for greater liquidity and trading as there are more shares available, and more people feel confident about the company. It also makes it easier for institutions to buy, as they don't want to own so many shares they have a huge percentage of the company.

Everything about this stock indicates to hold, and buy. In fact, the high price of the shares may have been holding it back.

I'm also surprised people would talk so much and so desperately about selling. It's talking down the value of your own investment and makes selling at a good price less likely, so why would one do that and announce repeatedly you want to sell your stock?

I bought a little more at $28. I keep assuming when it hits the 30s it's not going to drop much but it hit 24.78 today. I keep averaging up -- now I'm at 23.71.

Sweden's Arcam soars in 3D printing boom

http://money.msn.com/business-news/article.aspx?symbol=US:DDD&feed=OBR&date=20140123&id=17283856

It already did pullback for some time. There's not necessarily an immediate pullback when it goes up after being down a long time. There has been a lot of new buying which buyers would have no reason to sell since they just bought it.

I don't see any point in selling. The stock should continue upward.

Ameritrade must physically receive the shares from the company through the transfer agent before they can be in the account, and they haven't received them.

In this case the transfer agent is JP Morgan and the standard time for receiving shares after a split is 3-5 days. AT has been given no date or notice when the shares might arrive.

Shares are not actually (and magically) "split." New shares are delivered into your account from the company.

According to Ameritrade, they must physically receive the shares from the company through the transfer agent before they can be in the account, and they haven't received them.

In this case the transfer agent is JP Morgan and the standard time for receiving shares after a split is 3-5 days. AT has been given no date or notice when the shares might arrive.

It may take a while for the changes to be made. The record date is January 23rd.

"First day of trading after the split is Tuesday on January 21, 2014."

It hasn't been that low since September 16th. Many thousands of shares have been purchased much higher than $102.50. Being up $40 a share is nothing to sneeze at. My average is $156.

Needham presentation -- you need to click on slides yourself to keep up (at least I did).

http://wsw.com/webcast/needham64/OTIV/

I didn't think it would tumble this much with the low float and I thought there might be a lot of buyers waiting in the high 20's, low 30's, but apparently not.

There is definitely selling going on. The pps has dropped almost to my average.

It looks like there's a seller on PFHO. That's a couple days of selling now. My last buy was at 29.55. My average is 22.90 now. With this drop I might put in a bid for more.

There is not one yet. It is to be announced.

Stocks go up and down. I bought more at 29.55. I guess I could have set a lower bid.

Oops. Apparently it is. I don't know why it was put out with today's date by this publication.

Arcam offers large EBM system for Additive Manufacturing in the aerospace industry

6th Jan, 2014

Sweden’s Arcam AB has recently launched the Arcam Q20, a new Electron Beam Melting (EBM) system designed specifically for manufacturing in the aerospace industry. The new EBM system was developed with support from leading aerospace manufacturers and is based on Arcam’s Q10 technology platform but with a larger build envelope (Ø350×380 mm).

Arcam is primarily active in two market segments, the aerospace and the orthopaedic implant industries. The orthopaedic industry started using EBM systems in 2007, and today the process is well established with more than 30,000 EBM-manufactured orthopaedic devices implanted worldwide.

The aerospace industry is about to move into series production for several product applications, states Arcam, and the new Arcam Q20 provides several new features for industrial volume production, including increased productivity, higher resolution, and a camera-based monitoring system for part quality verification.

“With Arcam Q20 we sharpen our offering to one of our main markets, the aerospace industry. Arcam Q20 represents a new EBM generation, with a focus on continued industrialisation of the technology”, stated Magnus René, CEO of Arcam. “Arcam Q20 strengthens our already strong product program for aerospace manufacturing, a market that puts high demands on both the technology and the application expertise. The first Arcam Q20 user will be Poly-Shape in France.”

http://www.ipmd.net/news/002537.html